Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.
Masoodi M, Gastaldelli A, Hyötyläinen T, Arretxe E, Alonso C, Gaggini M, Brosnan J, Anstee QM, Millet O, Ortiz P, Mato JM, Dufour JF, Orešič M. Masoodi M, et al. Among authors: mato jm. Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):835-856. doi: 10.1038/s41575-021-00502-9. Epub 2021 Sep 10. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34508238 Review.
S-adenosyl-L-methionine and the liver.
Ortiz P, Moreno J, Puerta JL, Mato JM. Ortiz P, et al. Among authors: mato jm. Ital J Gastroenterol. 1993 Apr;25(3):135-7. Ital J Gastroenterol. 1993. PMID: 8507890 No abstract available.
Metabolism of methionine in liver disease.
Mato JM, Ortiz P. Mato JM, et al. Methods Find Exp Clin Pharmacol. 1996;18 Suppl B:35-46. Methods Find Exp Clin Pharmacol. 1996. PMID: 8899692 Review. No abstract available.
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.
Barr J, Vázquez-Chantada M, Alonso C, Pérez-Cormenzana M, Mayo R, Galán A, Caballería J, Martín-Duce A, Tran A, Wagner C, Luka Z, Lu SC, Castro A, Le Marchand-Brustel Y, Martínez-Chantar ML, Veyrie N, Clément K, Tordjman J, Gual P, Mato JM. Barr J, et al. Among authors: mato jm. J Proteome Res. 2010 Sep 3;9(9):4501-12. doi: 10.1021/pr1002593. J Proteome Res. 2010. PMID: 20684516 Free PMC article.
Non-alcoholic fatty liver disease proteomics.
Rodríguez-Suárez E, Duce AM, Caballería J, Martínez Arrieta F, Fernández E, Gómara C, Alkorta N, Ariz U, Martínez-Chantar ML, Lu SC, Elortza F, Mato JM. Rodríguez-Suárez E, et al. Among authors: mato jm. Proteomics Clin Appl. 2010 Apr;4(4):362-71. doi: 10.1002/prca.200900119. Epub 2010 Feb 3. Proteomics Clin Appl. 2010. PMID: 21137056 Free PMC article.
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.
Barr J, Caballería J, Martínez-Arranz I, Domínguez-Díez A, Alonso C, Muntané J, Pérez-Cormenzana M, García-Monzón C, Mayo R, Martín-Duce A, Romero-Gómez M, Lo Iacono O, Tordjman J, Andrade RJ, Pérez-Carreras M, Le Marchand-Brustel Y, Tran A, Fernández-Escalante C, Arévalo E, García-Unzueta M, Clement K, Crespo J, Gual P, Gómez-Fleitas M, Martínez-Chantar ML, Castro A, Lu SC, Vázquez-Chantada M, Mato JM. Barr J, et al. Among authors: mato jm. J Proteome Res. 2012 Apr 6;11(4):2521-32. doi: 10.1021/pr201223p. Epub 2012 Mar 15. J Proteome Res. 2012. PMID: 22364559 Free PMC article.
Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.
Gonzalez E, van Liempd S, Conde-Vancells J, Gutierrez-de Juan V, Perez-Cormenzana M, Mayo R, Berisa A, Alonso C, Marquez CA, Barr J, Lu SC, Mato JM, Falcon-Perez JM. Gonzalez E, et al. Among authors: mato jm. Metabolomics. 2012;8(6):997-1011. doi: 10.1007/s11306-011-0329-9. Epub 2011 Jul 14. Metabolomics. 2012. PMID: 23139648 Free PMC article.
395 results